Orikines’s Website

Barcelona, ES · 2 known investors

Orikine Bio develops precision-engineered bi-specific cytokine therapies ("Foldikines") that reprogram immune signaling to treat severe autoimmune and inflammatory diseases. It is a biotechnology company operating a proprietary cytokine engineering platform.